Adoptive Cell Transfer (ACT) is an immunotherapy approach that involves the extraction, enhancement, and reinfusion of a patient's own immune cells to target and destroy cancer cells. This personalized treatment aims to boost the body's natural defenses by enhancing the cancer-fighting capabilities of T cells, often through genetic modification or selection of tumor-infiltrating lymphocytes.